Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
10
Nov |
Mesothelioma Breath Test HopeCategory: Asbestos / Mesothelioma | Leave a Comment |
Researchers from Italy and The Netherlands have developed an “electronic nose” that appears to be able to tell if someone has Malignant Pleural Mesothelioma (MPM) just from sampling their breath. A report on their study is currently in press but an early issue recently appeared online in the journal Lung Cancer…
|
4
May |
Novel Noninvasive Tests For Early Cancer DetectionCategory: Asbestos / Mesothelioma | Leave a Comment |
Researchers at last month’s AACR conference in Orlando demonstrated that they are intensifying their efforts to identify and validate various types of biomarkers that are detectable in readily accessible bodily fluids such as blood and urine, reports Genetic Engineering & Biotechnology News (GEN)…
|
5
Apr |
Early-Stage, Asbestos-Related Pulmonary Cancer Detected By Protein TestCategory: Asbestos / Mesothelioma | Leave a Comment |
Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6…
|
24
Aug |
New Technique Can Help Diagnose MesotheliomaCategory: Asbestos / Mesothelioma | Leave a Comment |
A new technique may help clinicians hone in on a diagnosis in patients presenting with a pleural effusion of unknown cause. The study, led by principal investigator Y.C. Gary Lee, Ph.D., appears in the September 1 issue of the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.